Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-17-064811

Options or other derivatives

  • Director acquired 47,165 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Director 2017-12-07 Grant or award · Stock Option (right to buy) +47,165 47,165 D: show line 1 in the form
Loading xslF345X03/doc4.xml…